Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients.
van Nunen
A B
AB
de Man
R A
RA
Heijtink
R A
RA
Niesters
H G
HG
Schalm
S W
SW
D005260:Female; D019694:Hepatitis B, Chronic / Q000517:prevention & control*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019259:Lamivudine / Q000627:therapeutic use*; D011247:Pregnancy; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014766:Viremia / Q000517:prevention & control* / Q000635:transmission*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine